Trinity Biotech PLC (TRIB)
| Market Cap | 42.43M |
| Revenue (ttm) | 101.98M |
| Net Income (ttm) | -6.39M |
| Shares Out | 20.90M |
| EPS (ttm) | -0.09 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 125,654 |
| Open | 2.15 |
| Previous Close | 2.18 |
| Day's Range | 1.98 - 2.17 |
| 52-Week Range | 1.75 - 6.82 |
| Beta | 1.69 |
| Analysts | Strong Buy |
| Price Target | 7.00 (+244.8%) |
| Est. Earnings Date | n/a |
About TRIB
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the United States, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other ...
Financial Performance
In 2020, TRIB's revenue was $101.98 million, an increase of 12.77% compared to the previous year's $90.44 million. Losses were -$6.39 million, -77.91% less than in 2019.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for TRIB stock is "Strong Buy" and the 12-month stock price forecast is 7.00.
News
Trinity Biotech Announces Results for Q2, 2021
DUBLIN, Ireland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 Financial Results
Conference Call Scheduled for September 9, 2021 at 11:00 am EASTERN Conference Call Scheduled for September 9, 2021 at 11:00 am EASTERN
Trinity Biotech Provides A Business Development Update For Q2 2021
DUBLIN, Ireland, July 16, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) provides a business development update for Q2 2021.
Trinity Biotech Announces Results for Q1, 2021
DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, t...
Trinity Biotech plc to Announce First Quarter Fiscal Year 2021 Financial Results
Conference Call Scheduled for May 25, 2021 at 11:00 am EASTERN Conference Call Scheduled for May 25, 2021 at 11:00 am EASTERN
Top Penny Stocks For Your May Watchlist? Check These 5 Out
Looking for penny stocks to buy in May 2021? Here's some watchlist inspiration The post Top Penny Stocks For Your May Watchlist?
Trinity Biotech Announces Quarter 4 and Fiscal Year 2020 Financial Results
DUBLIN, Ireland, March 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2020 Financial Results
Conference Call Scheduled for March 25, 2021 at 11:00 am EASTERN Conference Call Scheduled for March 25, 2021 at 11:00 am EASTERN
5 Irish Stocks To Buy For St. Patrick's Day
For many people, St. Patrick's Day means a corned beef and cabbage dinner, a pint of Guinness and watching “The Quiet Man” for the 100th time. For investors seeking to add a breath of fresh Eire in thei...
Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test
DUBLIN, Ireland, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved CE Mark approval and registration for its Covid-19 IgG ELISA antibody test, the Captia™ SARS-CoV-2 IgG ...
Is Trinity Biotech plc (TRIB) A Good Stock To Buy?
Is Trinity Biotech plc (NASDAQ:TRIB) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investor...
Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q3 2020 Results - Earnings Call Transcript
Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q3 2020 Results - Earnings Call Transcript
Trinity Biotech Announces Results for Q3, 2020
DUBLIN, Ireland, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, ...
Trinity Biotech plc to Announce Third Quarter 2020 Financial Results
Conference Call Scheduled for November 17, 2020 at 11:00 am EASTERN Conference Call Scheduled for November 17, 2020 at 11:00 am EASTERN
Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q2 2020 Results - Earnings Call Transcript
Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q2 2020 Results - Earnings Call Transcript
Trinity Biotech Announces Results for Q2, 2020
DUBLIN, Ireland, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...
Trinity Biotech announces EUA submission for Covid-19 ELISA Antibody test
DUBLIN, Ireland, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...
Trinity Biotech plc to Announce Second Quarter 2020 Financial Results
Conference Call Scheduled for August 25, 2020 at 11:00am EASTERN Conference Call Scheduled for August 25, 2020 at 11:00am EASTERN
Why Trinity Biotech's Stock Is Trading Lower Today
Trinity Biotech (NASDAQ: TRIB) shares are trading lower on Monday after the company's subsidiary Primus Corp announced it received an FDA warning letter following an inspection of Kansas City Manufactur...
Trinity Biotech subsidiary, Primus Corporation Receives FDA Warning Letter
DUBLIN, Ireland, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...
Trinity Biotech's (TRIB) CEO Ronan O'Caoimh on Q1 2020 Results - Earnings Call Transcript
Trinity Biotech's (TRIB) CEO Ronan O'Caoimh on Q1 2020 Results - Earnings Call Transcript
Trinity Biotech Announces Results for Q1, 2020
DUBLIN, Ireland, May 27, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech plc's (TRIB) CEO Ronan O'Caoimh on Q4 2019 Results - Earnings Call Transcript
Trinity Biotech plc's (TRIB) CEO Ronan O'Caoimh on Q4 2019 Results - Earnings Call Transcript
What Trinity Bio Brings to the Fight Against COVID-19
Trinity Biotech PLC (NASDAQ: TRIB) released its fiscal fourth-quarter financial results on Tuesday morning, but that wasn’t what propelled the stock afterward.
Penny Stocks to Buy Using Technical Analysis for March 2020
Penny stocks can be dangerous, particularly in this economic environment – so quick thinking and stop losses will be your best friends.